High‐throughput screening and biological display technology: Applications in molecular imaging
iRADIOLOGY · 2023
DOI: 10.1002/ird3.11 ↗At a glance
Journal article in iRADIOLOGY, 2023. Written by Renli Luo and 2 co-authors. Cited 19 times so far (Crossref); 86 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Molecular imaging plays important roles in many fields, including disease diagnosis, therapeutic efficacy evaluation, intraoperative imaging guidance, drug metabolism monitoring, and patient selection for appropriate treatment. As a key component, the targeting ligand determines the specificity, affinity, and in vivo performance of molecular imaging probes. In this review, high‐throughput screening and biological display platforms for the discovery of ligands applicable to molecular imaging are briefly reviewed. Basic information on ligand development for molecular imaging is first introduced, followed by a presentation of various selection platforms and typical or iterative cases. The features, advantages, limitations, and application scope of screening and display platforms are compared and discussed. Last, a basic selection strategy and a perspective for protein‐based ligands are provided.
Cite
APA
Luo, R., Liu, H., & Cheng, Z. (2023). High‐throughput screening and biological display technology: Applications in molecular imaging. iRADIOLOGY. https://doi.org/10.1002/ird3.11
Vancouver
Luo R, Liu H, Cheng Z. High‐throughput screening and biological display technology: Applications in molecular imaging. iRADIOLOGY. 2023. doi:10.1002/ird3.11
BibTeX
@article{Luo2023,
author = {Luo, Renli and Liu, Hongguang and Cheng, Zhen},
title = {High‐throughput screening and biological display technology: Applications in molecular imaging},
journal = {iRADIOLOGY},
year = {2023},
doi = {10.1002/ird3.11}
}
EUVIMED